Kidney Cancer News & Features
Use of either Nexavar (sorafenib) or Sutent (sunitinib) provide no benefit to patients with locally advanced renal cell carcinoma.
In situations where small renal tumors confined to the kidneys, active monitoring, as opposed to immediate surgery, is associated with low rates of tumor growth or mortality.
In patients likely to have surgery, close monitoring of small renal tumors is associated with low rates of cancer growth or mortality.
A test that has the potential to improve treatment of patients with clear cell renal cell carcinoma (ccRCC).
Organ preservation in kidney cancer more likely at facilities that are early adopters of robotic surgery
Patients with operable kidney cancers were more likely to have a partial nephrectomy, which is the recommended treatment for localized tumors, when treated in hospitals that were early adopters of robotic surgery, according to a new study.
Kidney Cancer Videos
Kidney Cancer Clinical Trials
- New treatment method shrinks ovarian cancer tumors and improves chemotherapy effectiveness
- Women educated on overdiagnsosis are less likely to want mammogram
- Epigenetic signatures differentiate triple negative breast cancers
- Novel drug approved for multiple myeloma
- Radiation therapy used most often for prostate cancer regardless of decision-making factors
- Farydak (panobinostat) now FDA-approved for multiple myeloma
- ASCO: Testicular cancer history may indicate greater risk of developing prostate cancer
- Urine test could help to guide treatment of bladder cancer
- Multiple studies are exploring whether e-cigarettes help smokers quit or continue smoking
- Study identifies reasons for ibrutinib discontinuation in patients with chronic lymphocytic leukemia
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|